HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Miyakawa Selected Research

Poly(ADP-ribose) Polymerase Inhibitors

1/2022Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Miyakawa Research Topics

Disease

5Neoplasms (Cancer)
02/2024 - 10/2019
3Pancreatic Neoplasms (Pancreatic Cancer)
02/2024 - 10/2019
2Infections
11/2023 - 01/2022
1Hepatitis B
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2019
1Colonic Neoplasms (Colon Cancer)
10/2019

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2019
2RNA (Ribonucleic Acid)IBA
02/2024 - 10/2019
1Double-Stranded RNA (RNA, Double Stranded)IBA
02/2024
1cabozantinibIBA
11/2023
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2022
1LipidsIBA
12/2022
1Glucose (Dextrose)FDA LinkGeneric
12/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022
1cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
01/2020
1micaIBA
01/2020
1Circular RNAIBA
10/2019